PARP inhibitors are a class of drugs that block the enzyme poly (ADP-ribose) polymerase, which helps repair DNA damage in cells. By inhibiting this enzyme, PARP inhibitors can prevent cancer cells, particularly those with BRCA1 or BRCA2 mutations, from repairing their DNA, leading to cell death.
